Skip to main content

Hip Fractures

4
Pipeline Programs
13
Companies
22
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
3
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

12 companies ranked by most advanced pipeline stage

Innovation Pharmaceuticals
7 programs
1
PFNA AugmentationPhase 41 trial
All treatments will remain the standardN/A1 trial
Application of knowledgeN/A1 trial
Geriatric Fracture Centers - Evaluation of a Geriatric Co-management ProgramN/A1 trial
Latin America Hip Fracture Mortality StudyN/A1 trial
+2 more programs
Active Trials
NCT04113044Active Not Recruiting1,500Est. Dec 2026
NCT02272972Completed250Est. May 2016
NCT02297581Completed282Est. May 2020
+4 more trials
JW Pharmaceutical
JW PharmaceuticalKorea - Seoul
1 program
1
FerinjectPhase 41 trial
Active Trials
NCT05429749Unknown264Est. Dec 2024
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
1
Tranexamic AcidPhase 41 trial
Active Trials
NCT02580227Unknown100Est. Mar 2017
Viking Therapeutics
Viking TherapeuticsCA - San Diego
1 program
1
VK5211Phase 21 trial
Active Trials
NCT02578095Completed108Est. Dec 2017
Stamford Pharmaceuticals
3 programs
HemiarthroplastyN/A1 trial
Internal fixationN/A1 trial
Uncemented Furlong HemiarthroplastyN/A1 trial
Active Trials
NCT02998359Completed300Est. Jul 2019
NCT02996383Unknown50
NCT02998034Completed400Est. Jul 2019
Jerusalem Pharmaceuticals
Jerusalem PharmaceuticalsIsrael - Ramallah
2 programs
CO - OPN/A1 trial
Cognitive Orientation to Occupational PerformanceN/A1 trial
Active Trials
NCT03376750Unknown90Est. Mar 2019
NCT03300219Unknown6Est. Mar 2019
Zimmer Biomet
Zimmer BiometFL - Jacksonville
2 programs
G7 Acetabular SystemN/A1 trial
Uncemented femoral stemN/A1 trial
Active Trials
NCT04031209Active Not Recruiting275Est. Mar 2028
NCT02247791Unknown140Est. Sep 2024
Amgen
AmgenTHOUSAND OAKS, CA
1 program
ActiveHip+ mobile applicationN/A1 trial
Active Trials
NCT04859309Unknown104Est. Dec 2021
Corin
CorinUK - Cirencester
1 program
Bipolar i and cemented stemN/A1 trial
Active Trials
NCT05686278Recruiting368Est. Sep 2035
Biocorp
BiocorpFrance - Issoire
1 program
PENG BLOCKN/A1 trial
Active Trials
NCT06457880Completed40Est. Jun 2024
Enterprise Therapeutics
1 program
Patient Pathway Pharmacist interventionN/A1 trial
Active Trials
NCT03695081Completed60Est. Jun 2023
Fresenius Kabi
Fresenius KabiGermany - Bad Homburg
1 program
hemodynamic optimisation guided using esophageal DopplerPHASE_31 trial
Active Trials
NCT00444262Terminated215Est. Mar 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
JW PharmaceuticalFerinject
Oregon TherapeuticsTranexamic Acid
Innovation PharmaceuticalsPFNA Augmentation
Fresenius Kabihemodynamic optimisation guided using esophageal Doppler
Viking TherapeuticsVK5211
Innovation PharmaceuticalsLow-risk subgroup
CorinBipolar i and cemented stem
BiocorpPENG BLOCK
AmgenActiveHip+ mobile application
Innovation PharmaceuticalsAll treatments will remain the standard
Zimmer BiometG7 Acetabular System
Innovation PharmaceuticalsValidation of Two Acitivity Monitors in Three Inpatient Populations.
Enterprise TherapeuticsPatient Pathway Pharmacist intervention
Jerusalem PharmaceuticalsCognitive Orientation to Occupational Performance
Jerusalem PharmaceuticalsCO - OP

Showing 15 of 22 trials with date data

Clinical Trials (22)

Total enrollment: 5,067 patients across 22 trials

NCT05429749JW PharmaceuticalFerinject

Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery

Start: Jul 2020Est. completion: Dec 2024264 patients
Phase 4Unknown
NCT02580227Oregon TherapeuticsTranexamic Acid

Tranexamic Acid in Intertrochanteric and Subtrochanteric Femur Fractures

Start: Jun 2015Est. completion: Mar 2017100 patients
Phase 4Unknown
NCT01473082Innovation PharmaceuticalsPFNA Augmentation

Proximal Femoral Nail Antirotation (PFNA) Versus PFNA Augmentation

Start: Feb 2012Est. completion: Jan 2016251 patients
Phase 4Completed
NCT00444262Fresenius Kabihemodynamic optimisation guided using esophageal Doppler

Stroke Volume Optimisation in Patients With Hip Fracture

Start: Apr 2007Est. completion: Mar 2011215 patients
Phase 3Terminated
NCT02578095Viking TherapeuticsVK5211

Acute Hip Fracture Study in Patients 65 Years or Greater

Start: Oct 2015Est. completion: Dec 2017108 patients
Phase 2Completed
NCT06014554Innovation PharmaceuticalsLow-risk subgroup

Structured Tailored Rehabilitation After Hip Fragility Fracture

Start: Apr 2024Est. completion: Jun 202560 patients
N/ARecruiting
NCT05686278CorinBipolar i and cemented stem

Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty

Start: Jun 2023Est. completion: Sep 2035368 patients
N/ARecruiting
NCT06457880BiocorpPENG BLOCK

PENG Block vs FNB + ONB in Patients Undergoing Hip Fracture Surgery With Contraindications to Neuraxial Anesthesia

Start: Jan 2022Est. completion: Jun 202440 patients
N/ACompleted
NCT04859309AmgenActiveHip+ mobile application

Activating Older People After a Hip Fracture

Start: Jun 2021Est. completion: Dec 2021104 patients
N/AUnknown
NCT04113044Innovation PharmaceuticalsAll treatments will remain the standard

Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®

Start: Feb 2021Est. completion: Dec 20261,500 patients
N/AActive Not Recruiting
NCT04031209Zimmer BiometG7 Acetabular System

G7 Dual Mobility System Used in Total Hip Arthroplasty for the Treatment of Femoral Neck Fracture

Start: Jan 2020Est. completion: Mar 2028275 patients
N/AActive Not Recruiting
NCT04120740Innovation PharmaceuticalsValidation of Two Acitivity Monitors in Three Inpatient Populations.

Validation of Two Acitivity Monitors in Three Inpatient Populations.

Start: Oct 2019Est. completion: Nov 201936 patients
N/ACompleted
NCT03695081Enterprise TherapeuticsPatient Pathway Pharmacist intervention

Patient Pathway Pharmacist - Optimal Drug-related Care

Start: Sep 2018Est. completion: Jun 202360 patients
N/ACompleted
NCT03300219Jerusalem PharmaceuticalsCognitive Orientation to Occupational Performance

Tele-rehabilitation Intervention for People Post Hip Fracture - Pilot Study

Start: Jan 2017Est. completion: Mar 20196 patients
N/AUnknown
NCT03376750Jerusalem PharmaceuticalsCO - OP

Tele-rehabilitation Intervention for People Post Hip Fracture - Randomized Controlled Trial (RCT)

Start: Jan 2017Est. completion: Mar 201990 patients
N/AUnknown
NCT02996383Stamford PharmaceuticalsInternal fixation

Fixation Versus Arthroplasty for Undisplaced Intracapsular Fractures

Start: May 201650 patients
N/AUnknown
NCT02297581Innovation PharmaceuticalsGeriatric Fracture Centers - Evaluation of a Geriatric Co-management Program

Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program

Start: May 2015Est. completion: May 2020282 patients
N/ACompleted
NCT02272972Innovation PharmaceuticalsApplication of knowledge

Performance Improvement Program on Imaging II

Start: Oct 2014Est. completion: May 2016250 patients
N/ACompleted
NCT02998359Stamford PharmaceuticalsHemiarthroplasty

Hemiarthroplasty Versus Total Hip Replacement for Intracapsular Hip Fractures

Start: Aug 2013Est. completion: Jul 2019300 patients
N/ACompleted
NCT02998034Stamford PharmaceuticalsUncemented Furlong Hemiarthroplasty

Cemented Hemiarthroplasty Versus Uncemented Furlong Hemiarthroplasty

Start: Aug 2013Est. completion: Jul 2019400 patients
N/ACompleted
NCT01650064Innovation PharmaceuticalsLatin America Hip Fracture Mortality Study

Latin America Hip Fracture Mortality Study

Start: Jan 2013Est. completion: Dec 2016168 patients
N/ACompleted
NCT02247791Zimmer BiometUncemented femoral stem

Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty

Start: Sep 2009Est. completion: Sep 2024140 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 5,067 patients
13 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.